M. Tamura et al., Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts, EUR J PHARM, 386(2-3), 1999, pp. 289-295
The present study examines the effect of lipopolysaccharides and proinflamm
atory cytokines on the expression of the second isoform of the angiotensin
II receptor (AT(2)), which may have a role in lowering collagen deposition
in cardiac tissue. Cardiac fibroblasts express high levels of both angioten
sin II type 1 (AT(1)) and type 2 receptors. Incubation with lipopolysacchar
ides for 24 h dose- and time-dependently decreased angiotensin II AT(2) rec
eptor expression with no apparent difference in the affinity. Actinomycin D
, cycloheximide, N-omega-nitro-L-arginine methyl ester and the protein tyro
sine kinase inhibitor herbimycin A, but not the protein kinase C inhibitors
bisindolylmaleimide and calphostin C, abolished the inhibitory action of l
ipopolysaccharides. The cytokines interleukin-1 beta and tissue necrosis fa
ctor-alpha mimicked the effect of lipopolysaccharides. All three compounds
induced inducible nitric oxide synthase (iNOS). The nitric oxide donor sodi
um nitroprusside and the cGMP analog 8-bromoguanosine cyclic monophosphate
downregulated angiotensin II AT(2) receptor expression. The findings are co
nsistent with the pathway in which lipopolysaccharides or cytokines induce
iNOS. The data suggest that lipopolysaccharide- or cytolkine-dependent indu
ction of iNOS and resultant production of nitric oxide leads to the product
ion of cGMP, which in turn downregulates expression of the angiotensin Il A
T(2) receptor in cardiac fibroblasts. (C) 1999 Elsevier Science B.V. All ri
ghts reserved.